Clinical Trial

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate the efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-07-30; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2024-04-29
Trial Details
NCT Number NCT05484908
Lead Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Conditions Immune-Mediated Hepatitis, Liver Failure, Hepatocellular Carcinoma
Enrollment 60 participants
Start Date 2022-08-12
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-29